RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) today announced that it has completed a sale of CBTE stock subject to a $1 million put right with Venturepharm Laboratories, Ltd. (“VPL”) (HKEX:8225.HK). Under the terms of the put agreement, CBI sold 463,426 shares of common stock to VPL at a price of $2.15 per share, a 56% premium to the June 30, 2008 share price of $1.38.
